Dr. Kannan Vishwanatth to establish World-Class Herbal Research Centre in Riga, Latvia

New Delhi : The Rupus Global Herbal & Research & Development Institute, situated in Hong Kong, aims to be a leading institution in the study, dissemination, preservation, and promotion of Ayurveda’s medicinal herbs. The Institute will become a leading herbal destination for the healthy lives of national and worldwide communities, and a pioneering centre of excellence in Latvian herbal medicine. Ecotourism and the growing of medicinal and aromatic plants in Latvia will be encouraged by the Rupus Global Herbal & Research & Development Center. Establishing the Centre for Medicinal Plants Research is crucial to Rupus Global Herbal & Research & Development Institute’s pursuit of loftier goals in the field of medicinal plants research.

Announcing the initiatives, Prof. Dr. Kannan Vishwanatth, founder chairman of Rupus Global Limited remarked “The Baltic state of Latvia, an EU member is a country on the south-eastern shore of the Baltic Sea between Lithuania and Estonia. Global Economic Research estimates that there are 1.8 million people living in Latvia, and their GDP per person, adjusted for purchasing power parity, is $41,474. The core missions of the Rupus Global Herbal & Research & Development Institute are to conduct studies in the following areas: clinical research, basic research, pharmacology (pre-clinical safety/toxicity and biological activity studies), medicinal plants (medico-ethno botanic survey, cultivation, pharmacognosy), and drug standardisation.

It is estimated that 122 medications have been identified from 94 different plant species using ethnobotanical data as a starting point. For a variety of illnesses, Latvian locals turned to plants native to the country’s land. Even if they didn’t know much about the chemistry of plants, the locals would still have access to a wealth of information about medicinal plants that might be used to cure a wide range of illnesses. From what can be gleaned from the historical documentation of Latvian folk medicine, oral dosing of herbal remedies appears to have been the most prevalent, straightforward, and rapid method of delivery. Several historical accounts cite the direct application of plant leaves to fresh wounds or insect or animal bites for their anti-inflammatory and wound-healing effects. These leaves include plantain, yarrow, aloe, and apple tree. During Latvia’s presidency, the country’s agriculture ministry has prioritised expanding organic farming, which makes about 11% of the sector. When compared to the overall amount of farmland in the country, Latvia has the highest percentage of organic farms among the countries that are part of the European Union.

Rupus Global Herbal & Research & Development Institute will be set up in a phased manner. We are in the process of identifying the land & building the proposed institute with the support of the authorities, to promote herbal medicine among the people, Cultivation of prioritized medicinal plants on farmers’ land & establishing nurseries with backward linkages for raising and supplying quality planting material. The venture will be built on a public-private partnership.

Gradually, we have plans to set up an herbal educational institute, to showcase Latvia’s rich farming heritage. Rupus Global Herbal & Research & Development Institute’s objective will be to promote better health through evidence-based Ayurveda principles and practices, to develop the center into a dynamic, vibrant, and model research organization for the undertaking, coordinating, aiding, and promoting research in Ayurveda, to bring-up modern scientific knowledge, technology to explore Ayurveda scientific treasure following prevalent scientific methods & to attain global leadership in research for treatment and prevention of emerging important lifestyle-related disease and health requirement.

Visionary entrepreneur Dr. Kannan Vishwanatth based out of Riga, Latvia is the Founder & Managing Director of our Hong Kong-based pharmaceutical company Rupus Global Limited. He holds a doctorate in Business Management (Ph.D.). Dr. Kannan Vishwanatth is a global opinion maker on contemporary issues & a much sought-after speaker in various international forums. As a Research Scholar, Dr. Kannan has published many research papers & is associated with many top-notch International Institutions as Editorial Reviewer. Dr. Kannan Vishwanatth is a global Citizen & a strong believer in Corporate Social Responsibilities.

Over the years, Dr. Kannan has slowly transitioned away from Corporate World and into philanthropic & academic ventures. Dr. Kannan Vishwanatth is a top academic researcher at the Garwood Innovation Fellow at Garwood Centre of Open Innovation, Haas School of Business Berkeley University of California & Senior Research Scholar at the Latvian Academy of Sciences in Riga. Dr. Vishwanatth further pursued higher studies at the University of Azteca European Programs. Having mastered Chemical Engineering, Vishwanatth started his entrepreneurial journey a decade ago and formed a successful mid-sized pharmaceutical company with a major thrust on API (Active Pharmaceutical Ingredient). Dr. Kannan Vishwanatth along with Prof. Solomon Darwin, Director, Garwood Center for Corporate Innovation, Executive Director, Center for Growth Markets, Institute for Business Innovation & Dr. Satya Brahma, Chairman & Editor-In-Chief, Network 7 Media Group, Founder & Chairman, Pharma Leaders & India Leadership Conclave co-authored a research book on Smart Villages – A Game-Changing Innovations in Social Engineering in the year 2022.